BLUE

bluebird bio (BLUE)

About bluebird bio (BLUE)

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Details

Daily high

$4.99

Daily low

$4.97

Price at open

$4.98

52 Week High

$28.60

52 Week Low

$3.20

Market cap

48.8M

Dividend yield

0.00%

Volume

482,952

Avg. volume

824,896

P/E ratio

-.24

bluebird bio News